Scarica l'app Stockscreener
144.01
1.67%
2.36
Dopo l'orario di chiusura:
140.44
-3.57
-2.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$141.65
Aprire:
$141.63
Volume 24 ore:
2.65M
Relative Volume:
0.86
Capitalizzazione di mercato:
$30.44B
Reddito:
$398.11M
Utile/perdita netta:
$-1.03B
Rapporto P/E:
-25.31
EPS:
-5.69
Flusso di cassa netto:
$-868.57M
1 W Prestazione:
-0.94%
1M Prestazione:
+5.81%
6M Prestazione:
+88.77%
1 anno Prestazione:
+97.27%
Intervallo 1D:
$141.00
$145.41
Intervallo di 1 settimana:
$134.01
$145.56
Portata 52W:
$60.40
$149.08
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
144.01 | 29.94B | 398.11M | -1.03B | -868.57M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Iniziato | William Blair | Outperform |
| 2025-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Iniziato | Jefferies | Buy |
| 2025-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
Insmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A Optionality - Seeking Alpha
Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% - Yahoo Finance
S&P 500 Futures Decline in Premarket Trading; Firefly Aerospace, Insmed Lag - Barron's
Real time breakdown of Insmed Incorporated stock performanceQuarterly Profit Review & Low Risk Entry Point Guides - newser.com
How buyback programs support Insmed Incorporated (IM8N) stockShort Setup & AI Enhanced Trade Execution Alerts - newser.com
Public Employees Retirement System of Ohio Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Goldman's 48 potential M&A candidates (INSM:NASDAQ) - Seeking Alpha
Is Insmed Incorporated a good long term investmentSector Performance Review & Build Winning Portfolio - earlytimes.in
Insmed Incorporated Stock Analysis and ForecastInsider Trading Compliance & Access Free Tools and Start Investing - Early Times
RBC Capital Remains Bullish on Insmed Incorporated (INSM) - Yahoo Finance
Assenagon Asset Management S.A. Buys 33,626 Shares of Insmed, Inc. $INSM - MarketBeat
Longboard Asset Management LP Acquires New Position in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated to Present Multiple Abstracts At the European Respiratory Society Congress 2025 - MarketScreener
Cystic Fibrosis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Insmed Inc, AstraZeneca, Zambon, CSL Behring, Chiesi Farmaceutici - The Globe and Mail
Insmed to Present Phase 2b TPIP and Phase 3 ASPEN Trial Data at ERS Congress 2025 - geneonline.com
Insmed (INSM) Highlights Phase 2 and Phase 3 Trial Data at ERS 2025 Congress - GuruFocus
Late-Breaking PAH Treatment Data: Insmed's TPIP Phase 2b Results Lead 7 Presentations at ERS Congress 2025 - Stock Titan
Harbor Capital Advisors Inc. Sells 26,030 Shares of Insmed, Inc. $INSM - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Makes New $452,000 Investment in Insmed, Inc. $INSM - MarketBeat
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 202522.09.25News - Ariva
Weekly Trades: Will Insmed Incorporated outperform its industry peersMarket Activity Report & Risk Controlled Daily Plans - خودرو بانک
Strs Ohio Purchases Shares of 25,700 Insmed, Inc. $INSM - MarketBeat
Dividend Watch: Whats the beta of Insmed Incorporated stockMarket Trend Summary & Precise Swing Trade Alerts - خودرو بانک
Rep. Gilbert Ray Cisneros, Jr. Sells Insmed, Inc. (NASDAQ:INSM) Shares - MarketBeat
Signal Recap: Is Insmed Incorporated stock good for income investorsWeekly Volume Report & Precise Swing Trade Entry Alerts - khodrobank.com
Is Insmed Incorporated stock a smart retirement pick2025 Price Momentum & AI Powered Buy/Sell Recommendations - khodrobank.com
Insmed (NASDAQ:INSM) Insider Orlov S. Nicole Schaeffer Sells 76,520 Shares - MarketBeat
Melvin Md Sharoky Sells 10,000 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Insmed, Inc. $INSM Shares Bought by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):